Anthracycline cardiotoxicity and lymphoma

ISSN： 1865-5041

Source： memo - Magazine of European Medical Oncology, Vol.7, Iss.1, 2014-02, pp. : 43-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anthracycline-induced chronic cardiotoxicity and heart failure

By Appel Jon M. Nielsen Dorte Zerahn Bo Jensen Benny V. Skagen Knud

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 576-580

Informa Healthcare

Access to resources Recommend Favorite

Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-01 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism

By Cusack B. Gambliel H. Musser B. Hadjokas N. Shadle S. Charlier H. Olson R.

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 517-526

Springer Publishing Company

Access to resources Recommend Favorite

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)

By Ryu Jung Lee Hong Hong Young-Soo Lee Jung Sohn Uy Kim Tae

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 283-284

Springer Publishing Company

Access to resources Recommend Favorite

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)

By Ryu Jung Lee Hong Hong Young-Soo Lee Jung Sohn Uy Kim Tae

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 811-818

Springer Publishing Company

Access to resources Recommend Favorite